Follow
Ildikó Seres
Ildikó Seres
senior research fellow, University of Debrecen, Faculty of Medicine
Verified email at belklinika.com
Title
Cited by
Cited by
Year
Study of factors influencing the decreased HDL associated PON1 activity with aging
I Seres, G Paragh, E Deschene, T Fulop Jr, A Khalil
Experimental gerontology 39 (1), 59-66, 2004
2592004
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
G Kerekes, Z Szekanecz, H Dér, Z Sándor, G Lakos, L Muszbek, I Csipö, ...
The Journal of rheumatology 35 (3), 398-406, 2008
2502008
Rheumatoid arthritis and metabolic syndrome
G Kerekes, MT Nurmohamed, MA Gonzalez-Gay, I Seres, G Paragh, ...
Nature Reviews Rheumatology 10 (11), 691-696, 2014
2262014
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
G Paragh, P Balla, E Katona, I Seres, A Égerházi, I Degrell
European archives of psychiatry and clinical neuroscience 252, 63-67, 2002
1662002
Assessment of subclinical vascular disease associated with ankylosing spondylitis
N Bodnár, G Kerekes, I Seres, G Paragh, J Kappelmayer, ZG Némethné, ...
The Journal of Rheumatology 38 (4), 723-729, 2011
1412011
Modulation of human lymphocyte proliferative response with aging
N Douziech, I Seres, A Larbi, E Szikszay, PM Roy, M Arcand, G Dupuis, ...
Experimental gerontology 37 (2-3), 369-387, 2002
1412002
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia
G Paragh, I Seres, Z Balogh, Z Varga, I Kárpáti, J Mátyus, L Újhelyi, ...
Nephron 80 (2), 166-170, 1998
1381998
Serum paraoxonase activity changes in uremic and kidney-transplanted patients
G Paragh, L Asztalos, I Seres, Z Balogh, L Löcsey, I Kárpáti, J Mátyus, ...
Nephron 83 (2), 126-131, 1999
1181999
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage
M Harangi, I Seres, Z Varga, G Emri, Z Szilvássy, G Paragh, É Remenyik
European Journal of Clinical Pharmacology 60, 685-691, 2004
1112004
Association of chemerin with oxidative stress, inflammation and classical adipokines in non‐diabetic obese patients
P Fülöp, I Seres, H Lőrincz, M Harangi, S Somodi, G Paragh
Journal of cellular and molecular medicine 18 (7), 1313-1320, 2014
852014
Vitamin D insufficiency in a large MCTD population
A Hajas, J Sandor, L Csathy, I Csipo, S Barath, G Paragh, I Seres, ...
Autoimmunity reviews 10 (6), 317-324, 2011
812011
Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus
E Kiss, I Seres, T Tarr, Z Kocsis, G Szegedi, G Paragh
Annals of the New York Academy of Sciences 1108 (1), 83-91, 2007
802007
Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Z Balogh, I Seres, M Harangi, P Kovacs, GY Kakuk, GY Paragh
Diabetes and Metabolism 27 (5; PART 1), 604-610, 2001
802001
The effect of atorvastatin therapy on lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase
A Kassai, L Illyés, HZ Mirdamadi, I Seres, T Kalmár, M Audikovszky, ...
Clinical biochemistry 40 (1-2), 1-5, 2007
792007
The human paraoxonase‐1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters
HZ Mirdamadi, F Sztanek, Z Derdak, I Seres, M Harangi, G Paragh
British journal of clinical pharmacology 66 (3), 366-374, 2008
732008
Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels
P Koncsos, I Seres, M Harangi, I Illyés, L Józsa, F Gönczi, L Bajnok, ...
Pediatric research 67 (3), 309-313, 2010
702010
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease
G Paragh, I Seres, M Harangi, Z Balogh, L Illyes, J Boda, Z Szilvássy, ...
Diabetes & metabolism 29 (6), 613-618, 2003
702003
Determination of DNA damage induced by oxidative stress in hyperlipidemic patients
M Harangi, É Remenyik, I Seres, Z Varga, E Katona, G Paragh
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 513 (1-2 …, 2002
652002
Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro
Z Varga, I Seres, E Nagy, L Ujhelyi, G Balla, J Balla, S Antus
Phytomedicine 13 (1-2), 85-93, 2006
622006
High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus
K Gaál, T Tarr, H Lőrincz, V Borbás, I Seres, M Harangi, P Fülöp, ...
Lipids in health and disease 15, 1-8, 2016
602016
The system can't perform the operation now. Try again later.
Articles 1–20